Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Syndax Pharmaceuticals (SNDX) Cost of Revenue (2024 - 2026)

Syndax Pharmaceuticals has reported Cost of Revenue over the past 3 years, most recently at $11.8 million for Q1 2026.

  • For Q1 2026, Cost of Revenue rose 1238.53% year-over-year to $11.8 million; the TTM value through Mar 2026 reached $31.0 million, up 433.12%, while the annual FY2025 figure was $33.8 million, 585.17% up from the prior year.
  • Cost of Revenue for Q1 2026 was $11.8 million at Syndax Pharmaceuticals, up from $9.6 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $11.8 million in Q1 2026 and troughed at $885000.0 in Q1 2025.
  • A 3-year average of $6.1 million and a median of $6.6 million in 2024 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: surged 94.58% in 2025 and later skyrocketed 1238.53% in 2026.
  • Year by year, Cost of Revenue stood at $4.9 million in 2024, then skyrocketed by 94.58% to $9.6 million in 2025, then rose by 23.49% to $11.8 million in 2026.
  • Business Quant data shows Cost of Revenue for SNDX at $11.8 million in Q1 2026, $9.6 million in Q4 2025, and $8.3 million in Q3 2025.